Evidence map›Paper›PMID 20026127›Full record

ArticleJournal of molecular and cellular cardiology2010

Ca(2+)/calmodulin-dependent protein kinase II contributes to intracellular pH recovery from acidosis via Na(+)/H(+) exchanger activation.

Martín Vila-Petroff, Cecilia Mundiña-Weilenmann, Noelia Lezcano, Andrew K Snabaitis, María Ana Huergo, Carlos A Valverde, Metin Avkiran, Alicia Mattiazzi

Open access · greenAbstract read
In one paragraph

Article in Journal of molecular and cellular cardiology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 55 citations in OpenAlex.

  1. Review
  2. Article
  3. Direct cardiac effects of SGLT2 inhibitors.Cardiovascular diabetology · 2022
    Review
  4. Review
  5. Cardioprotection by SGLT2 Inhibitors-Does It All Come Down to NaInternational journal of molecular sciences · 2021
    Review
  6. Role of Genetic Mutations of the NaMolecular and cellular biochemistry · 2021
    Review
  7. CaMKIIδ Splice Variants in the Healthy and Diseased Heart.Frontiers in cell and developmental biology · 2021
    Review
  8. Article
  9. NaThe Journal of physiology · 2017
    Article
  10. Article
  11. Article
  12. Chasing cardiac physiology and pathology down the CaMKII cascade.American journal of physiology. Heart and circulatory physiology · 2015
    Review
  13. Review
  14. Article
  15. Review
  16. Review
  17. Review
  18. Article
  19. Platelet-activating factor stimulates sodium-hydrogen exchange in ventricular myocytes.American journal of physiology. Heart and circulatory physiology · 2011
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Martín Vila-PetroffCentro de Investigaciones Cardiovasculares, CCT-La Plata CONICET, Facultad de Ciencias Médicas, Universidad Nacional de La Plata, 60 y 120 (1900) La Plata, Argentina.
Cecilia Mundiña-Weilenmann
Noelia Lezcano
Andrew K Snabaitis
María Ana Huergo
Carlos A Valverde
Metin Avkiran
Alicia Mattiazzi
Universidad Nacional de La Plata · ARSt Thomas' Hospital · GB

Funding

Role of CaMKII in the irreversible ischemia-reperfusion cardiac injuryR03TW007713 · FIC · CENTRO DE INVESTIGACIONES CARDVIOVASCULA · PI MATTIAZZI, ALICIA · 2007 to 2009
$97k
FIC NIH HHS R03 TW007713FIC NIH HHS R03TW07713
6 · The paper itself

Abstract

The Na(+)/H(+) exchanger (NHE-1) plays a key role in pH(i) recovery from acidosis and is regulated by pH(i) and the ERK1/2-dependent phosphorylation pathway. Since acidosis increases the activity of Ca(2+)/calmodulin-dependent protein kinase II (CaMKII) in cardiac muscle, we examined whether CaMKII activates the exchanger by using pharmacological tools and highly specific genetic approaches. Adult rat cardiomyocytes, loaded with the pH(i) indicator SNARF-1/AM were subjected to different protocols of intracellular acidosis. The rate of pH(i) recovery from the acid load (dpH(i)/dt)-an index of NHE-1 activity in HEPES buffer or in NaHCO(3) buffer in the presence of inhibition of anion transporters-was significantly decreased by the CaMKII inhibitors KN-93 or AIP. pH(i) recovery from acidosis was faster in CaMKII-overexpressing myocytes than in overexpressing beta-galactosidase myocytes (dpH(i)/dt: 0.195+/-0.04 vs. 0.045+/-0.010 min(-)(1), respectively, n=8) and slower in myocytes from transgenic mice with chronic cardiac CaMKII inhibition (AC3-I) than in controls (AC3-C). Inhibition of CaMKII and/or ERK1/2 indicated that stimulation of NHE-1 by CaMKII was independent of and additive to the ERK1/2 cascade. In vitro studies with fusion proteins containing wild-type or mutated (Ser/Ala) versions of the C-terminal domain of NHE-1 indicate that CaMKII phosphorylates NHE-1 at residues other than the canonical phosphorylation sites for the kinase (Ser648, Ser703, and Ser796). These results provide new mechanistic insights and unequivocally demonstrate a role of the already multifunctional CaMKII on the regulation of the NHE-1 activity. They also prove clinically important in multiple disorders which, like ischemia/reperfusion injury or hypertrophy, are associated with increased NHE-1 and CaMKII.

Indexed as

AcidosisAnimalsBenzenesulfonamidesBenzopyransBenzylaminesbeta-GalactosidaseCalcium-Calmodulin-Dependent Protein Kinase Type 2CytoplasmMiceMice, TransgenicMyocardiumMyocytes, CardiacNaphtholsPhosphorylationRatsRats, WistarBenzenesulfonamidesBenzopyransBenzylaminesbeta-GalactosidaseCalcium-Calmodulin-Dependent Protein Kinase Type 2KN 93NaphtholsRhodaminesseminaphthorhodaminefluorideSodium-Hydrogen ExchangersSulfonamides

Identifiers

PMID20026127
PMCPMC2883686
OpenAlexW2056680550

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.